{"id":2421,"date":"2023-03-02T00:00:00","date_gmt":"2023-03-02T05:00:00","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/"},"modified":"2023-03-02T00:00:00","modified_gmt":"2023-03-02T05:00:00","slug":"herpes-zoster-hz-complications-and-prevention-strategies","status":"publish","type":"blog","link":"https:\/\/www.mdbriefcase.com\/fr\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/","title":{"rendered":"Herpes Zoster (HZ) Complications and Prevention Strategies"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Herpes zoster is a vaccine-preventable disease that can result in long-term and serious complications. This program will discuss the most likely potential complications associated with HZ and which people are at high risk of complications, and will also review NACI recommendations for vaccination against HZ.\u00a0<\/span><\/p>\n<h2><b>What is herpes zoster? Who is at risk?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Herpes zoster, more commonly known as shingles, is a condition that causes painful rashes to appear on the skin. These rashes usually last between two to four weeks and may appear anywhere on the body. HZ is caused by the varicella-zoster virus (VZV) \u2014 the same pathogen responsible for chickenpox.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Shingles can only appear in people who have already been infected with VZV. At first contact with this virus, a person will develop chickenpox. After recovery, however, the virus will remain inactive in the body. Herpes zoster appears when it reactivates \u2014 yet, how this reactivation happens isn\u2019t fully understood.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As such, the only people at risk of herpes zoster are those who have had chickenpox at some point. Persons with compromised immune systems (due to either drugs or medical conditions) are at an even greater risk of developing shingles. Similarly, older people are also more prone to HZ due to lower resistance to the virus.<\/span><\/p>\n<h2><b>What is the prevalence and burden of herpes zoster?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Research shows that while chickenpox incidence has significantly decreased recently, herpes zoster has <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8941701\/\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">become<\/span><\/a> <span style=\"font-weight: 400;\">more prevalent. It\u2019s estimated that 7.2 out of 1000 persons will develop HZ at some point in their lives. This number increases with age: 8.45 for people between 50 and 59, and 10.46 for people older than 60.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It\u2019s estimated that over 95 percent of the world population above 50 has been exposed to the varicella-zoster virus, meaning that most older people are at risk of developing HZ. This is even truer for people who haven\u2019t been vaccinated for VZV \u2014 unvaccinated people over 85 have a 50 percent chance of developing shingles.<\/span><\/p>\n<h2><b>What are the potential long-term and severe complications of HZ?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Most people who get HZ won\u2019t have any further complications \u2014 however, up to 18 percent of people will develop a long-term condition known as <\/span><a href=\"https:\/\/www.cdc.gov\/shingles\/about\/complications.html\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">postherpetic neuralgia<\/span><\/a><span style=\"font-weight: 400;\"> (PHN). PHN usually occurs where the HZ rash was, causing severe pain that may last for years, often requiring medication.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Less commonly, shingles may lead to other complications, including:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Eye conditions, including blindness<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hearing problems<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pneumonia<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Infection of the lesions<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hepatitis<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Encephalitis<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Up to <\/span><a href=\"https:\/\/www.cdc.gov\/shingles\/surveillance.html\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">4 percent<\/span><\/a><span style=\"font-weight: 400;\"> of people with herpes zoster will require hospitalization due to these complications. In the most severe cases, HZ may even lead to death. It\u2019s estimated that herpes zoster deaths have a prevalence of between 0.28 to 0.69 per 1 million people. Older people and those with compromised immune systems are more at risk of developing severe complications from shingles.<\/span><\/p>\n<h2><b>What are the available evidence and new indications for recombinant zoster vaccine?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">A recent systematic review of the available evidence regarding herpes zoster vaccines found that vaccination can <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9561817\/\" target=\"_blank\" rel=\"nofollow noopener\"><span style=\"font-weight: 400;\">offer<\/span><\/a><span style=\"font-weight: 400;\"> significant protection against this virus. Currently, there are two vaccines available for HZ: recombinant zoster vaccine (RZV) and zoster vaccine live (ZVL).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to that same study, RZV is the better option for preventing HZ, offering a relative efficacy of 84 percent and a relative effectiveness of 49 percent. Relative efficacy refers to the protection this vaccine provides under ideal circumstances, while relative effectiveness indicates its superiority when compared to the existing medical treatments.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">On the other hand, ZVL efficacy declines with age, making it less useful for older people who are arguably more at risk of developing severe HZ-related consequences. Furthermore, ZVL can slightly increase the incidence of adverse complications and may not be as effective when dealing with immunocompromised subjects.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As such, vaccination with RZV is the most promising prevention strategy for herpes zoster, showing very few safety concerns and high efficiency. However, more research may be required before establishing RZV as the standard strategy for HZ.<\/span><\/p>\n<h2><b>What are the NACI recommendations for HZ prevention?<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The National Advisory Committee on Immunization (NACI) recommends administering vaccines to every person over 50 without contraindications. RZV is preferred over ZVL \u2014 however, ZVL may be considered whenever RZV is contraindicated or otherwise unavailable.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">NACI also recommends paying attention to the duration of protection, as RZV starts being less efficient after four years and ZVL after three. Therefore, a second dose is recommended after a year has passed since the first immunization.<\/span><\/p>\n<h2><b>Learning more about HZ<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Research regarding treatment options and prevention strategies for herpes zoster is still underway. You\u00a0can learn more about HZ in our <\/span><a href=\"https:\/\/www.mdbriefcase.com\/fr\/course\/herpes-zoster-hz-complications-and-prevention-strategies\/?region=CAN-eng\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">complimentary course<\/span><\/a><span style=\"font-weight: 400;\">. Join the <\/span><a href=\"https:\/\/www.mdbriefcase.com\/fr\/user-account\/?action=eb_register&amp;utm_source=blog&amp;utm_medium=cta&amp;utm_campaign=hz\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">MDBriefCase<\/span><\/a><span style=\"font-weight: 400;\"> community for free to stay current on clinical guidelines.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Herpes zoster is a vaccine-preventable disease that can result in long-term and serious complications. This program will discuss the most likely potential complications associated with HZ and which people are at high risk of complications, and will also review NACI recommendations for vaccination against HZ.\u00a0 What is herpes zoster? Who is at risk? Herpes zoster, [&hellip;]<\/p>\n","protected":false},"featured_media":2422,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"categories":[64],"class_list":["post-2421","blog","type-blog","status-publish","has-post-thumbnail","hentry","category-deep-understandingfurther-educationlearning-and-development"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Herpes Zoster (HZ) Complications and Prevention Strategies - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Herpes Zoster (HZ) Complications and Prevention Strategies - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Herpes zoster is a vaccine-preventable disease that can result in long-term and serious complications. This program will discuss the most likely potential complications associated with HZ and which people are at high risk of complications, and will also review NACI recommendations for vaccination against HZ.\u00a0 What is herpes zoster? Who is at risk? Herpes zoster, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/\",\"name\":\"Herpes Zoster (HZ) Complications and Prevention Strategies - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg\",\"datePublished\":\"2023-03-02T05:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg\",\"width\":1200,\"height\":733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Herpes Zoster (HZ) Complications and Prevention Strategies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Herpes Zoster (HZ) Complications and Prevention Strategies - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/","og_locale":"fr_CA","og_type":"article","og_title":"Herpes Zoster (HZ) Complications and Prevention Strategies - MDBriefCase","og_description":"Herpes zoster is a vaccine-preventable disease that can result in long-term and serious complications. This program will discuss the most likely potential complications associated with HZ and which people are at high risk of complications, and will also review NACI recommendations for vaccination against HZ.\u00a0 What is herpes zoster? Who is at risk? Herpes zoster, [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/","og_site_name":"MDBriefCase","og_image":[{"width":1200,"height":733,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/","url":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/","name":"Herpes Zoster (HZ) Complications and Prevention Strategies - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg","datePublished":"2023-03-02T05:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2025\/04\/Herpes-Zoster-Complications-and-Prevention-Strategies.jpg","width":1200,"height":733},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/blog\/herpes-zoster-hz-complications-and-prevention-strategies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Herpes Zoster (HZ) Complications and Prevention Strategies"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/blog\/2421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/blog"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/2422"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=2421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/categories?post=2421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}